Poor glycemic control and abrupt onset of diabetes in HCV patients receiving direct-acting antiviral drugs: case series (original) (raw)
Rapid Decline of Fasting Glucose in HCV Diabetic Patients Treated with Direct Acting Antiviral Agents
I. Mezzaroma
Clinical Microbiology and Infection, 2016
View PDFchevron_right
Hepatitis C Treatment by Directly Acting Antiviral Agents and Its Impact on Glycemic Control
UBEDULLAH SHAIKH
Journal of Pharmaceutical Research, 2021
View PDFchevron_right
Direct Acting Antiviral and Glycemic Control In Patients with Hepatitis C
Asmaa Ahmed
2021
View PDFchevron_right
Treatment of Chronic Hepatitis C Can Improve Glycemic Control in Patients with Type 2 Diabetes
Meltem Sertbas
Case Reports in Hepatology
View PDFchevron_right
The Effect of Viral Clearance Achieved by Direct-Acting Antiviral Agents on Hepatitis C Virus Positive Patients with Type 2 Diabetes Mellitus: A Word of Caution after the Initial Enthusiasm
Marco Sacco
Journal of Clinical Medicine
View PDFchevron_right
Glucose and Lipid Profile Changes in Hepatitis C Patients After Direct Acting Antivirals Therapy
Mohamed Sharaf-Eldin
International Journal of TROPICAL DISEASE & Health, 2021
View PDFchevron_right
Effect of eradication of HCV infection by direct-acting antivirals in diabetic HCV-infected patients as regards glycemic control
Mohamed El-badry
Egyptian Liver Journal, 2020
View PDFchevron_right
Glucose Metabolism Changes in Patients with Chronic Hepatitis C Treated with Direct Acting Antivirals
Mária Szántová
View PDFchevron_right
Significant improvement of glycemic control in diabetic patients with HCV infection responding to direct-acting antiviral agents
Marco Sacco
Journal of Medical Virology
View PDFchevron_right
Impact of Direct Acting Antivirals for Treatment of Chronic Hepatitic C Virus Infection on Glycemic Control in Egyptian Patients with Type 2 Diabetes Mellitus
Arafat Kassem
View PDFchevron_right
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents
Carlo Smirne
PLOS ONE
View PDFchevron_right
Over time evaluation of glycaemic control in direct‐acting antiviral‐treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis
Irene Cacciola
Liver International, 2021
View PDFchevron_right
Evaluating the Effects of Anti-Viral Therapy on Insulin Resistance and Diabetic Status in Chronic Hepatitis C patients
Fadia Mostafa
Afro-Egyptian Journal of Infectious and Endemic Diseases, 2020
View PDFchevron_right
Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients
Dr.Mohammed Mohammed
Minia Journal of Medical Research, 2019
View PDFchevron_right
Metabolic Impact of Diabetes Mellitus Type 2 in Hepatitis C Virus Infected Patients
ADINA KAMAL
Current Health Sciences Journal, 2021
View PDFchevron_right
The impact of direct-acting antiviral treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients: temporary? permanent?
Engin Altintas
The Turkish journal of gastroenterology, 2020
View PDFchevron_right
Glucose Abnormalities in Patients with Hepatitis C Virus Infection
Antonio Picardi
Diabetes Care, 2006
View PDFchevron_right
Change in insulin resistance according to virological response during antiviral treatment for hepatitis C virus infection
Jawtown Lin
Advances in Digestive Medicine, 2016
View PDFchevron_right
Time-course of insulin resistance during antiviral therapy in non-diabetic non-cirrhotic patients with genotype 1 HCV infection
Giulio Marchesini
Digestive and Liver Disease, 2009
View PDFchevron_right
Insulin resistance does not impair response of chronic hepatitis C virus to direct-acting antivirals, and improves with the treatment
Mohamed Hashim
European journal of gastroenterology & hepatology, 2018
View PDFchevron_right
The impact of a successful treatment of HCV on glyco-metabolic control in diabetic patients
Giulia Mosini
Antiviral Therapy
View PDFchevron_right
Sustained Virological Response Correlates With Reduction in the Incidence of Glucose Abnormalities in Patients With Chronic Hepatitis C Virus Infection
Cristina Hernandez
Diabetes Care, 2006
View PDFchevron_right
Insights on the disruption of glucose metabolism and hepatic insulin resistance induced by hepatitis C virus
Elvira del Pozo Maroto
Metabolism and Target Organ Damage, 2022
View PDFchevron_right
Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy
Wassim Chehadeh
Journal of Medical Virology, 2009
View PDFchevron_right
Metabolic changes in chronic hepatitis C patients receiving direct acting antivirals
Kadry Elsaeed
F1000Research
View PDFchevron_right
Insulin Resistance Reduction After Sustained Virological Response with Direct Acting Antiviral:Not Every Population Improves
Fábio Yamashiro
Arquivos de Gastroenterologia
View PDFchevron_right
High Prevalence of Glucose Abnormalities in Patients With Hepatitis C Virus Infection
Juan Antonio Verjano Esteban
Diabetes Care, 2004
View PDFchevron_right
Insulin Resistance and Prediabetes in Hepatitis C Virus Patients
zeinab kasemy
The American Journal of the Medical Sciences, 2015
View PDFchevron_right